Ms Gayle Denman > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Ms Gayle Denman
Work Department
Intellectual Property
Position
Associate
Career
Gayle Denman focuses her practice on trademark and other intellectual property matters, including trademark clearance, prosecution, maintenance, and enforcement. Ms. Denman has represented individual and corporate clients in a variety of industries, including media, entertainment, emerging technology, health care, fashion, and professional sports. She has experience drafting and negotiating a variety of intellectual property-related agreements and advising clients on trademark filing strategy, proceedings before the Trademark Trial and Appeal Board, and various other aspects of building and protecting brands in the United States and abroad.
Prior to joining Dechert, Ms. Denman served as an associate in the trademark and intellectual property practices of a leading national firm where she was named an Empire State Counsel of the New York Bar Association for substantial pro bono services. Her previous experience also includes working in the intellectual property and technology group of another international firm.
Education
- Massachusetts Institute of Technology (MIT), B.S., 2008, Phi Beta Kappa, Burchard Scholar
- Stanford Law School, J.D., 2011, Stanford Law Review
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation